Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

COVID-19 vaccine comparison adverse events Biontech vs Moderna 2020

As of mid-December 2020, the COVID-19 vaccine from the Biontech/Pfizer cooperation showed significant lower rates of severe adverse events than Moderna's product, with the exception of chills where Moderna showed a lower rate. During November, both sites reported nearly the exact same efficacy of around 95 percent of their vaccines.

Severe adverse events in COVID-19 vaccines developed by BioNTech/Pfizer and Moderna as of December 2020*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2020

Region

Worldwide

Survey time period

as of December 2020

Supplementary notes

* For Pfizer/Biontech, the briefing docs use "severe"; for Moderna, "Grade 3".

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.